- Advancing AML: The Use of Menin Inhibitors in NPM1-Mutated and KMT2A-Rearranged Disease
- Optimizing Outcomes in Polycythemia Vera
- Advances in CLL: Emerging Evidence and Optimizing Sequential Therapies
- Exploring Therapies in Newly Diagnosed and R/R MMM: Antibody-Drug Conjugates
- Live Q&A
OncLive® State of the Science Summit® Hematologic Malignancies
Kimpton Hotel Monaco Pittsburgh
620 William Penn Pl, Pittsburgh, PA 15219
Tuesday, December 8, 2026
6:00 PM-9:00 PM EDT
Registration is complimentary &
includes dinner and drinks
Event Chair

Kathleen A. Dorritie, MD
UPMC Hillman Cancer Center
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit® (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary and includes dinner, drinks, and entry into a raffle for a chance to win a gift of your choice.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831